Jakob Hirzel

ED Geistlich Söhne AG engages in the production of chemicals and related products. The firm offers its services through its divisions Geistlich Pharma AG, Geistlich Ligamenta AG, Geistlich Immobilia AG, Gewo GmbH, and Delta AG. Its activities include pharmaceuticals and biomaterials for medical applications, edible collagen foil for the meet processing industry, fats for cattle feed as well as adhesives for technical applications. The company was founded in 1851 and is headquartered in Zürich, Switzerland

Benninger Immobilien AG operates as a real estate agency. The acquires, manages, develops, rents, sells and finances land, homes, apartment buildings, factories and commercial properties in Switzerland and Germany. The company was founded in 1859 and is headquartered in Uzwil, Switzerland.

Migros-Genossenschafts-Bund engages in the operation of supermarkets and hypermarkets, specialist and do-it-yourself stores, discount shops, leisure facilities, and restaurants. It also specializes in the development and manufacture of products for the industry and wholesale sectors. The company was founded by Gottlieb Duttweiler on August 15, 1925 and is headquartered in Zurich, Switzerland.

BKW Energie AG engages in the production, transmission, and distribution of electricity. The firm also constructs and operates plants and provides engineering and energy-related services. The company was founded by Eduard Will in 1898 and is headquartered in Bern, Switzerland.

InSphero AG supplies organotypic 3D microtissues for efficiency testing and toxicology in drug development. It offers 3D insight Islet, 3D InSight Tumor, Gravity TRAP ULA Plates, Cytotoxicity Assay Kit, 3D InSight in Vitro Toxixology services, imaging and automation. he company was founded by Jan Lichtenberg, Jens M. Kelm, Simon P. Hoerstrup and Wolfgang Moritz on March 26, 2009 and is headquartered in Schlieren, Switzerland.

Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland.